Status: retired, Not sufficiently defined by necessary conditions definition status. Date: 08-Nov 2017. Module: SNOMED CT United Kingdom drug extension module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 102389601000001110 | Caffeine and Sodium Benzoate 500mg/2ml solution for injection vials (Imported (United States)) (product) | en | Fully specified name | Active | Entire term case sensitive | SNOMED CT United Kingdom drug extension module |
| 102389701000001117 | Caffeine and Sodium Benzoate 500mg/2ml solution for injection vials (Imported (United States)) | en | Synonym | Active | Entire term case sensitive | SNOMED CT United Kingdom drug extension module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Caffeine and Sodium Benzoate 500mg/2ml solution for injection vials (Imported (United States)) | Is a | Caffeine 250mg/2ml / Sodium benzoate 250mg/2ml solution for injection vials | false | Inferred relationship | Existential restriction modifier | ||
| Caffeine and Sodium Benzoate 500mg/2ml solution for injection vials (Imported (United States)) | Has active ingredient | Sodium benzoate | false | Inferred relationship | Existential restriction modifier | ||
| Caffeine and Sodium Benzoate 500mg/2ml solution for injection vials (Imported (United States)) | Has active ingredient | Caffeine | false | Inferred relationship | Existential restriction modifier | ||
| Caffeine and Sodium Benzoate 500mg/2ml solution for injection vials (Imported (United States)) | VMP prescribing status (attribute) | VMP valid as a prescribable product | false | Inferred relationship | Existential restriction modifier | ||
| Caffeine and Sodium Benzoate 500mg/2ml solution for injection vials (Imported (United States)) | VMP non-availability indicator | Available | false | Inferred relationship | Existential restriction modifier | ||
| Caffeine and Sodium Benzoate 500mg/2ml solution for injection vials (Imported (United States)) | Has specific active ingredient | Sodium benzoate | false | Inferred relationship | Existential restriction modifier | ||
| Caffeine and Sodium Benzoate 500mg/2ml solution for injection vials (Imported (United States)) | Has specific active ingredient | Caffeine anhydrous | false | Inferred relationship | Existential restriction modifier | ||
| Caffeine and Sodium Benzoate 500mg/2ml solution for injection vials (Imported (United States)) | Has dispensed dose form | Conventional release solution for injection | false | Inferred relationship | Existential restriction modifier | ||
| Caffeine and Sodium Benzoate 500mg/2ml solution for injection vials (Imported (United States)) | Has excipient | Excipient not declared | false | Inferred relationship | Existential restriction modifier | ||
| Caffeine and Sodium Benzoate 500mg/2ml solution for injection vials (Imported (United States)) | Is a | Actual medicinal product | false | Inferred relationship | Existential restriction modifier | ||
| Caffeine and Sodium Benzoate 500mg/2ml solution for injection vials (Imported (United States)) | Has manufactured dose form | Conventional release solution for injection | false | Inferred relationship | Existential restriction modifier |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Caffeine and Sodium Benzoate 500mg/2ml solution for injection vials (Imported (United States)) 10 vial | Has AMP | False | Caffeine and Sodium Benzoate 500mg/2ml solution for injection vials (Imported (United States)) | Inferred relationship | Existential restriction modifier |
This concept is not in any reference sets
FHIR